{"id":53,"date":"2020-03-24T17:46:45","date_gmt":"2020-03-24T20:46:45","guid":{"rendered":"http:\/\/template1.bs2.com.br\/profissionais-saude\/?p=53"},"modified":"2020-03-24T17:46:47","modified_gmt":"2020-03-24T20:46:47","slug":"odyssey-outcomes","status":"publish","type":"post","link":"https:\/\/www.prcardio.org\/profissionais-saude\/odyssey-outcomes\/","title":{"rendered":"ODYSSEY Outcomes"},"content":{"rendered":"<!--themify_builder_content-->\n<div id=\"themify_builder_content-53\" data-postid=\"53\" class=\"themify_builder_content themify_builder_content-53 themify_builder tf_clear\">\n    <\/div>\n<!--\/themify_builder_content-->\n\n\n<p>COLESTEROL<\/p>\n\n\n\n<p>Este estudo avaliou 18924 pacientes que tiverem um quadro de s\u00edndrome coronariana aguda com tratamento m\u00e1ximo tolerado de atorvastatina e rosuvastatina com LDL residual acima de 70 mg\/dl comparando placebo x alirocumab atingindo um LDL m\u00e9dio de 53 mg\/dl e evidenciando redu\u00e7\u00e3o de eventos cardiovasculares.<\/p>\n\n\n\n<p>Analisando os componentes individuais, os pesquisadores descobriram que o infarto do mioc\u00e1rdio n\u00e3o fatal foi reduzido em 14%, acidente vascular encef\u00e1lico em 27% e ngina inst\u00e1vel em 39% (todos significativos) com alirocumabe comparado ao placebo.Enquanto a taxa de mortalidade por todas as causas foi significativamente menor em 15% com alirocumab versus placebo (3,5 vs. 4,1%), n\u00e3o houve diferen\u00e7a significativa entre os grupos para morte por doen\u00e7a coronariana (2,2 vs. 2,3%) e morte cardiovascular<\/p>\n\n\n\n<p>O estudo FOURIER, publicado em 2017, com o evolocumab relatou uma redu\u00e7\u00e3o de 15% no risco de morte, infarto do mioc\u00e1rdio, acidente vascular cerebral, hospitaliza\u00e7\u00e3o por angina ou revasculariza\u00e7\u00e3o. Em compara\u00e7\u00e3o com FOURIER, o estudo ODYSSEY Outcomes inscreveu um grupo de pacientes de maior risco, teve uma dura\u00e7\u00e3o mais longa de acompanhamento (variando de dois a cinco anos), envolveu uma estrat\u00e9gia de dosagem diferente e teve um desfecho prim\u00e1rio ligeiramente diferente<\/p>\n\n\n\n<p><a href=\"https:\/\/www.acc.org\/latest-in-cardiology\/articles\/2018\/03\/05\/15\/53\/sat-9am-odyssey-outcomes-cv-outcomes-with-alirocum%20ab-after-acs-acc-2018\" target=\"_blank\" rel=\"noreferrer noopener\">https:\/\/www.acc.org\/latest-in-cardiology\/articles\/2018\/03\/05\/15\/53\/sat-9am-odyssey-outcomes-cv-outcomes-with-alirocum ab-after-acs-acc-2018<\/a><\/p>","protected":false},"excerpt":{"rendered":"<p>COLESTEROL Este estudo avaliou 18924 pacientes que tiverem um quadro de s\u00edndrome coronariana aguda com tratamento m\u00e1ximo tolerado de atorvastatina e rosuvastatina com LDL residual acima de 70 mg\/dl comparando placebo x alirocumab atingindo um LDL m\u00e9dio de 53 mg\/dl e evidenciando redu\u00e7\u00e3o de eventos cardiovasculares. Analisando os componentes individuais, os pesquisadores descobriram que o [&hellip;]<\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[4],"tags":[],"class_list":["post-53","post","type-post","status-publish","format-standard","hentry","category-estudo-clinico","has-post-title","has-post-date","has-post-category","has-post-tag","has-post-comment","has-post-author",""],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.4 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>SPC - Sociedade Paranaense de Cardiologia<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.prcardio.org\/profissionais-saude\/odyssey-outcomes\/\" \/>\n<meta property=\"og:locale\" content=\"pt_BR\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"SPC - Sociedade Paranaense de Cardiologia\" \/>\n<meta property=\"og:description\" content=\"COLESTEROL Este estudo avaliou 18924 pacientes que tiverem um quadro de s\u00edndrome coronariana aguda com tratamento m\u00e1ximo tolerado de atorvastatina e rosuvastatina com LDL residual acima de 70 mg\/dl comparando placebo x alirocumab atingindo um LDL m\u00e9dio de 53 mg\/dl e evidenciando redu\u00e7\u00e3o de eventos cardiovasculares. Analisando os componentes individuais, os pesquisadores descobriram que o [&hellip;]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.prcardio.org\/profissionais-saude\/odyssey-outcomes\/\" \/>\n<meta property=\"og:site_name\" content=\"SPC - Sociedade Paranaense de Cardiologia\" \/>\n<meta property=\"article:published_time\" content=\"2020-03-24T20:46:45+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2020-03-24T20:46:47+00:00\" \/>\n<meta name=\"author\" content=\"Hospedagem\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Hospedagem\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.prcardio.org\\\/profissionais-saude\\\/odyssey-outcomes\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.prcardio.org\\\/profissionais-saude\\\/odyssey-outcomes\\\/\"},\"author\":{\"name\":\"Hospedagem\",\"@id\":\"https:\\\/\\\/www.prcardio.org\\\/profissionais-saude\\\/#\\\/schema\\\/person\\\/a9b1dff39e9c1d3ba41de0f3dd6e1104\"},\"headline\":\"ODYSSEY Outcomes\",\"datePublished\":\"2020-03-24T20:46:45+00:00\",\"dateModified\":\"2020-03-24T20:46:47+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.prcardio.org\\\/profissionais-saude\\\/odyssey-outcomes\\\/\"},\"wordCount\":210,\"commentCount\":0,\"articleSection\":[\"Estudo Clinico\"],\"inLanguage\":\"pt-BR\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\\\/\\\/www.prcardio.org\\\/profissionais-saude\\\/odyssey-outcomes\\\/#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.prcardio.org\\\/profissionais-saude\\\/odyssey-outcomes\\\/\",\"url\":\"https:\\\/\\\/www.prcardio.org\\\/profissionais-saude\\\/odyssey-outcomes\\\/\",\"name\":\"SPC - Sociedade Paranaense de Cardiologia\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.prcardio.org\\\/profissionais-saude\\\/#website\"},\"datePublished\":\"2020-03-24T20:46:45+00:00\",\"dateModified\":\"2020-03-24T20:46:47+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.prcardio.org\\\/profissionais-saude\\\/#\\\/schema\\\/person\\\/a9b1dff39e9c1d3ba41de0f3dd6e1104\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.prcardio.org\\\/profissionais-saude\\\/odyssey-outcomes\\\/#breadcrumb\"},\"inLanguage\":\"pt-BR\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.prcardio.org\\\/profissionais-saude\\\/odyssey-outcomes\\\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.prcardio.org\\\/profissionais-saude\\\/odyssey-outcomes\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"In\u00edcio\",\"item\":\"https:\\\/\\\/www.prcardio.org\\\/profissionais-saude\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"ODYSSEY Outcomes\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.prcardio.org\\\/profissionais-saude\\\/#website\",\"url\":\"https:\\\/\\\/www.prcardio.org\\\/profissionais-saude\\\/\",\"name\":\"SPC - Sociedade Paranaense de Cardiologia\",\"description\":\"\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.prcardio.org\\\/profissionais-saude\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"pt-BR\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.prcardio.org\\\/profissionais-saude\\\/#\\\/schema\\\/person\\\/a9b1dff39e9c1d3ba41de0f3dd6e1104\",\"name\":\"Hospedagem\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"pt-BR\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/d1f33b566fe696af9b34d27adf7f4946e34028f4c303a6217cfc8e842e418d79?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/d1f33b566fe696af9b34d27adf7f4946e34028f4c303a6217cfc8e842e418d79?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/d1f33b566fe696af9b34d27adf7f4946e34028f4c303a6217cfc8e842e418d79?s=96&d=mm&r=g\",\"caption\":\"Hospedagem\"},\"url\":\"https:\\\/\\\/www.prcardio.org\\\/profissionais-saude\\\/author\\\/bs2\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"SPC - Sociedade Paranaense de Cardiologia","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.prcardio.org\/profissionais-saude\/odyssey-outcomes\/","og_locale":"pt_BR","og_type":"article","og_title":"SPC - Sociedade Paranaense de Cardiologia","og_description":"COLESTEROL Este estudo avaliou 18924 pacientes que tiverem um quadro de s\u00edndrome coronariana aguda com tratamento m\u00e1ximo tolerado de atorvastatina e rosuvastatina com LDL residual acima de 70 mg\/dl comparando placebo x alirocumab atingindo um LDL m\u00e9dio de 53 mg\/dl e evidenciando redu\u00e7\u00e3o de eventos cardiovasculares. Analisando os componentes individuais, os pesquisadores descobriram que o [&hellip;]","og_url":"https:\/\/www.prcardio.org\/profissionais-saude\/odyssey-outcomes\/","og_site_name":"SPC - Sociedade Paranaense de Cardiologia","article_published_time":"2020-03-24T20:46:45+00:00","article_modified_time":"2020-03-24T20:46:47+00:00","author":"Hospedagem","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Hospedagem","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.prcardio.org\/profissionais-saude\/odyssey-outcomes\/#article","isPartOf":{"@id":"https:\/\/www.prcardio.org\/profissionais-saude\/odyssey-outcomes\/"},"author":{"name":"Hospedagem","@id":"https:\/\/www.prcardio.org\/profissionais-saude\/#\/schema\/person\/a9b1dff39e9c1d3ba41de0f3dd6e1104"},"headline":"ODYSSEY Outcomes","datePublished":"2020-03-24T20:46:45+00:00","dateModified":"2020-03-24T20:46:47+00:00","mainEntityOfPage":{"@id":"https:\/\/www.prcardio.org\/profissionais-saude\/odyssey-outcomes\/"},"wordCount":210,"commentCount":0,"articleSection":["Estudo Clinico"],"inLanguage":"pt-BR","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/www.prcardio.org\/profissionais-saude\/odyssey-outcomes\/#respond"]}]},{"@type":"WebPage","@id":"https:\/\/www.prcardio.org\/profissionais-saude\/odyssey-outcomes\/","url":"https:\/\/www.prcardio.org\/profissionais-saude\/odyssey-outcomes\/","name":"SPC - Sociedade Paranaense de Cardiologia","isPartOf":{"@id":"https:\/\/www.prcardio.org\/profissionais-saude\/#website"},"datePublished":"2020-03-24T20:46:45+00:00","dateModified":"2020-03-24T20:46:47+00:00","author":{"@id":"https:\/\/www.prcardio.org\/profissionais-saude\/#\/schema\/person\/a9b1dff39e9c1d3ba41de0f3dd6e1104"},"breadcrumb":{"@id":"https:\/\/www.prcardio.org\/profissionais-saude\/odyssey-outcomes\/#breadcrumb"},"inLanguage":"pt-BR","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.prcardio.org\/profissionais-saude\/odyssey-outcomes\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/www.prcardio.org\/profissionais-saude\/odyssey-outcomes\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"In\u00edcio","item":"https:\/\/www.prcardio.org\/profissionais-saude\/"},{"@type":"ListItem","position":2,"name":"ODYSSEY Outcomes"}]},{"@type":"WebSite","@id":"https:\/\/www.prcardio.org\/profissionais-saude\/#website","url":"https:\/\/www.prcardio.org\/profissionais-saude\/","name":"SPC - Sociedade Paranaense de Cardiologia","description":"","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.prcardio.org\/profissionais-saude\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"pt-BR"},{"@type":"Person","@id":"https:\/\/www.prcardio.org\/profissionais-saude\/#\/schema\/person\/a9b1dff39e9c1d3ba41de0f3dd6e1104","name":"Hospedagem","image":{"@type":"ImageObject","inLanguage":"pt-BR","@id":"https:\/\/secure.gravatar.com\/avatar\/d1f33b566fe696af9b34d27adf7f4946e34028f4c303a6217cfc8e842e418d79?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/d1f33b566fe696af9b34d27adf7f4946e34028f4c303a6217cfc8e842e418d79?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/d1f33b566fe696af9b34d27adf7f4946e34028f4c303a6217cfc8e842e418d79?s=96&d=mm&r=g","caption":"Hospedagem"},"url":"https:\/\/www.prcardio.org\/profissionais-saude\/author\/bs2\/"}]}},"builder_content":"","_links":{"self":[{"href":"https:\/\/www.prcardio.org\/profissionais-saude\/wp-json\/wp\/v2\/posts\/53","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.prcardio.org\/profissionais-saude\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.prcardio.org\/profissionais-saude\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.prcardio.org\/profissionais-saude\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.prcardio.org\/profissionais-saude\/wp-json\/wp\/v2\/comments?post=53"}],"version-history":[{"count":1,"href":"https:\/\/www.prcardio.org\/profissionais-saude\/wp-json\/wp\/v2\/posts\/53\/revisions"}],"predecessor-version":[{"id":54,"href":"https:\/\/www.prcardio.org\/profissionais-saude\/wp-json\/wp\/v2\/posts\/53\/revisions\/54"}],"wp:attachment":[{"href":"https:\/\/www.prcardio.org\/profissionais-saude\/wp-json\/wp\/v2\/media?parent=53"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.prcardio.org\/profissionais-saude\/wp-json\/wp\/v2\/categories?post=53"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.prcardio.org\/profissionais-saude\/wp-json\/wp\/v2\/tags?post=53"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}